The fate of MAb-targeted Cd125mTe/ZnS nanoparticles in vivo
- 31 May 2008
- journal article
- Published by Elsevier BV in Nuclear Medicine and Biology
- Vol. 35 (4), 501-514
- https://doi.org/10.1016/j.nucmedbio.2008.02.001
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Preparation and characterization of radioactive dirhenium decacarbonyl-loaded PLLA nanoparticles for radionuclide intra-tumoral therapyEuropean Journal of Pharmaceutics and Biopharmaceutics, 2007
- Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI)Biomedical Microdevices, 2007
- Imaging of Vx‐2 rabbit tumors with ανβ3‐integrin‐targeted 111In nanoparticlesInternational Journal of Cancer, 2007
- Biodistribution and Pharmacokinetic Analysis of Long-Circulating Thiolated Gelatin Nanoparticles Following Systemic Administration in Breast Cancer-Bearing MiceJournal of Pharmaceutical Sciences, 2007
- Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug deliveryBiomaterials, 2006
- Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal ModelsCancer Research, 2006
- 99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistributionEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- In vivo tumor targeting of tumor necrosis factor-α-loaded stealth nanoparticles: Effect of MePEG molecular weight and particle sizeEuropean Journal of Pharmaceutical Sciences, 2006
- Pharmacokinetics and biodistribution of RGD-targeted doxorubicin-loaded nanoparticles in tumor-bearing miceInternational Journal of Pharmaceutics, 2005
- Magnetic Drug Targeting—Biodistribution of the Magnetic Carrier and the Chemotherapeutic agent Mitoxantrone after Locoregional Cancer TreatmentJournal of Drug Targeting, 2003